NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
1.265 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.008 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.001 | 0.001 | 0.001 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | 0.001 | 0 | 0.907 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.007 | 0.22 | 0.272 | 0.192 | 0 | 0 |
| Gross Profit
| -0.001 | -0.001 | 0.007 | -0.002 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0 | -0.001 | -0.001 | 0 | -0.907 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.007 | -0.22 | -0.272 | -0.192 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.875 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.804 | 1.748 | 2.534 | 3.314 | 3.873 | 3.65 | 4.456 | 4.129 | 2.958 | 5.483 | 6.413 | 6.276 | 4.659 | 2.909 | 4.299 | 4.332 | 1.39 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 4.246 | 4.25 | 1.872 | 2.494 | 4.065 | 5.785 | 5.432 | 5.012 | 6.642 | 10.222 | 46.562 | 13.823 | 12.458 | 2.101 | 6.541 | 3.754 | 0.526 | 0.001 | 0.001 | 0 | 0 | 0.163 | 0.322 | 0.22 | 0.272 | 0.192 | 0 | 0 |
| Selling & Marketing Expenses
| -0.001 | -0.001 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13,809.422 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.245 | 4.249 | 1.871 | 2.494 | 4.065 | 5.785 | 5.432 | 5.012 | 6.642 | 10.222 | 46.562 | 13.823 | 12.458 | 2.101 | 6.541 | 3.754 | 0.526 | 0.001 | 0.001 | 0.183 | 0.176 | 0.163 | 0.322 | 0.22 | 0.272 | 0.192 | 0.134 | 0 |
| Other Expenses
| -0.849 | 0 | 2.272 | 0 | -0.25 | -1.772 | 0 | 0 | 0 | 0 | -0 | 13,809.417 | -0.355 | -21.366 | 3.929 | -3.585 | -0.344 | 0.119 | 0.713 | 0.183 | 0.176 | 0.163 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 7.049 | 5.997 | 4.405 | 5.808 | 7.938 | 9.435 | 9.888 | 9.141 | 9.6 | 15.705 | 52.975 | 20.099 | 17.117 | 4.239 | 5.637 | 5.149 | -0.105 | 0.002 | 0.002 | 0.183 | 0.176 | 0.163 | 0.322 | 0.22 | 0.272 | 0.192 | 0.134 | 0 |
| Operating Income
| -7.05 | -5.998 | -4.406 | -5.808 | -8.188 | -9.435 | -9.888 | -9.141 | -9.6 | -15.705 | -52.976 | -20.099 | -17.117 | -25.605 | -45.123 | -5.149 | 0.105 | -0.001 | -0.002 | -0.183 | -0.176 | -0.163 | -0.322 | -0.22 | -0.272 | -0.192 | -0.134 | 0 |
| Operating Income Ratio
| 0 | 0 | -550.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.847 | -0.53 | 0.074 | -0.333 | -0.924 | -1.604 | -0.353 | 0.058 | 2.618 | 2.257 | 22.184 | -0.669 | 1.114 | -21.245 | -39.486 | 4.981 | -0.261 | -0 | -0 | 0.258 | 0.392 | 0.383 | 0.319 | 0.283 | 0.274 | 0.212 | 0.029 | 0 |
| Income Before Tax
| -7.897 | -6.528 | -4.332 | -6.062 | -8.717 | -11.039 | -10.241 | -9.083 | -6.982 | -13.448 | -30.793 | -20.773 | -16.008 | -25.489 | -45.128 | -5.162 | 0.102 | -0.002 | -0.002 | 0.075 | 0.217 | 0.22 | -0.003 | 0.063 | 0.002 | 0.02 | -0.105 | 0 |
| Income Before Tax Ratio
| 0 | 0 | -541.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.042 | -1.394 | 0.04 | -0.25 | 1.604 | -4.52 | -0.058 | -2.618 | -2.257 | -5.35 | 0.005 | 255.822 | -21.361 | -0.005 | -0.043 | -0.007 | 0.073 | -0.004 | 0.016 | 0.041 | 0.032 | -0.032 | 0.035 | 0.009 | 0.004 | 0 | 0 |
| Net Income
| -7.897 | -6.528 | -4.332 | -6.062 | -8.717 | -12.643 | -5.721 | -9.025 | -4.364 | -11.191 | -30.793 | -20.773 | -16.008 | -25.489 | -45.128 | -5.162 | 0.102 | -0.002 | -0.002 | 0.059 | 0.176 | 0.188 | 0.029 | 0.028 | -0.007 | 0.015 | -0.105 | 0 |
| Net Income Ratio
| 0 | 0 | -541.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.75 | -0.74 | -0.052 | -0.074 | -0.12 | -0.19 | -0.086 | -0.14 | -0.066 | -0.18 | -0.6 | -0.38 | -0.38 | -0.71 | -16.73 | -0.14 | 0.003 | -0.15 | -0.16 | 0.021 | 0.063 | 0.069 | 0.011 | 0.011 | -0.003 | 0.006 | -0.056 | 0 |
| EPS Diluted
| -0.75 | -0.74 | -0.052 | -0.074 | -0.12 | -0.19 | -0.086 | -0.14 | -0.066 | -0.18 | -0.6 | -0.38 | -0.38 | -0.71 | -16.73 | -0.14 | 0.003 | -0.15 | -0.16 | 0.021 | 0.063 | 0.069 | 0.011 | 0.011 | -0.003 | 0.006 | -0.056 | 0 |
| EBITDA
| -7.049 | -5.997 | -4.405 | -5.687 | -8.042 | -11.05 | -10.262 | -9.045 | -9.576 | -15.704 | -52.975 | -20.099 | -17.116 | -25.605 | -45.122 | -5.148 | 0.105 | -0.001 | -0.002 | 0.075 | 0.217 | 0.22 | -0.003 | 0.063 | 0.002 | 0.02 | -0.105 | 0 |
| EBITDA Ratio
| 0 | 0 | -550.625 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |